The rate of CD8+ T cells in early liver cancer cells is higher, showing a strong cytotoxic effect, whereas in advanced liver cancer cells, the proportion of depleted CD8+ T cells increases, the proportion of cytotoxic CD8+ T cells decreases, and the killing ability decreases [47]. The gene discussed is CD8A; the disease is liver cancer.